GGrantIndex
Sort

51,593 grants matching hepatitis

Molecular and structural characterization of broadly neutralizing anti-HCV antibodies

$744,817
Justin Richard Bailey · Johns Hopkins University · R01 · FY2017 · AI

Dissecting Hepatitis B Vaccine Adjuvant Effects on Immune Responses and the HIV Reservoir in PLWH

$744,728
Andrea L Cox · Johns Hopkins University · R01 · FY2024 · AI

Development and Evaluation of a Mobile Directly Observed Therapy Smartphone App for Immunosuppressive Adherence in Transplant Patients

$744,727
Sebastian Seiguer · Emocha Mobile Health, Inc. · R44 · FY2020 · DK

Hepatocyte TMEM141 in Lipoprotein Metabolism

$744,453
Yanqiao Zhang · University Of Arizona · R01 · FY2025 · HL

Motivational enhancement to augment contingency management for SARS-CoV-2 testing and vaccination utilization among syringe exchange clients

$744,388
Anne Marie Mauricio · University Of Oregon · U01 · FY2023 · DA

Understanding mechanisms of Fontan failure and key predictors for patient outcome

$744,227
Ajit P Yoganathan · Georgia Institute Of Technology · R01 · FY2012 · HL

Washington Entrepreneurial Research Evaluation and Commercialization Hub

$744,200
Rodney J.y. Ho · University Of Washington · U01 · FY2020 · HL

Validating a 3rd-generation methylation measure of accelerated aging: DunedinPoAm4x

$744,190
Terrie Edith Moffitt · Duke University · R01 · FY2023 · AG

Center for Humanized Mice

$744,154
Larisa Y Poluektova · University Of Nebraska Medical Center · R24 · FY2017 · OD

Development and Validation of Prognostic Radiomic Markers of Response and Recurrence for Patients with Colorectal Liver Metastases

$744,106
Richard Kinh Gian Do · Sloan-Kettering Inst Can Research · R01 · FY2019 · CA

Search For New and Emerging Etiologic Agents

$744,093
Robert H. Purcell · Niaid Extramural Activities · Z01 · FY2007 · AI

MR-Image Guided Focused Ultrasound for Treatment of Liver and Renal Cancer

$744,073
Kim Butts Pauly · Stanford University · R01 · FY2011 · CA

Pan-Genomic Approaches for Comprehensive Blood Screening of Novel or Emerging Infectious Agents

$744,018
Charles Yen Chiu · University Of California, San Francisco · R01 · FY2020 · HL

Equipment: MRI: Track 1. Acquisition of XtaLAB Synergy-R single crystal diffractometer.

$743,852
Sergey Korolev · Saint Louis University · · FY2024 · BIO

Allergen Loaded Nanoparticles for Food Allergy Tolerance

$743,761
Lonnie D Shea · University Of Michigan At Ann Arbor · R01 · FY2023 · AI

Understanding mechanisms of Fontan failure and key predictors for patient outcome

$743,611
Ajit P Yoganathan · Georgia Institute Of Technology · R01 · FY2011 · HL

At the Intersection of HIV and COVID-19: Medicaid Data as a Complement to Cohort Studies

$743,601
Bryan Lau · Johns Hopkins University · R01 · FY2023 · AI

Adverse metabolic effects of dietary sugar _ Ad libitum vs energy-balanced diets

$743,385
Peter J Havel · University Of California At Davis · R01 · FY2014 · HL

The Epidemiology of the Weiss Cohort Project

$743,331
Stanley H Weiss · Rutgers Biomedical And Health Sciences · R01 · FY2023 · DA

Non-esterified Fatty Acids and Cardiometabolic Disease in Older Adults

$743,268
Luc Djousse · Brigham And Women'S Hospital · R01 · FY2016 · AG

HIV and Hepatitis C Pathogenesis & The Human Genome

$743,251
David L Thomas · Johns Hopkins University · R01 · FY2015 · DA

Adiponectin and CTRP9 signaling in muscle and liver

$743,243
Harvey F Lodish · Whitehead Institute For Biomedical Res · R01 · FY2010 · DK

Miami Treatment and Prevention Clinical Trials Unit (CTU)

$743,160
Dushyantha Jayaweera · University Of Miami School Of Medicine · UM1 · FY2019 · AI

The Progression of Hepatitis C Among IDUs

$743,105
David L Thomas · Johns Hopkins University · R01 · FY2010 · DA

GLUCONEOGENESIS AND GLYCOGENOLYSIS--ROLE OF REGULATION

$743,088
Alan D Cherrington · Vanderbilt University · R37 · FY2007 · DK